缺少DEK会抑制线粒细胞吸收,以保护免受室内灰尘引发的喘
Qiaoyun Bai1,2, Ruobai Liu1,2, Changlin Quan1,2
1Jilin Key Laboratory for Immune and Targeting Research on Common Allergic Diseases, Yanbian University, Yanji, China.
Frontiers in immunology
|January 26, 2024
概括
德克蛋白通过促进线粒和炎症加剧喘. 针对DEK/ATAD3A/DRP1通路可能提供新的喘治疗方法.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 在喘中,DEK蛋白质的调节升高,但其在呼吸道炎症和线粒的确切作用尚不清楚.
- 了解DEK的机制对于开发有针对性的喘疗法至关重要.
研究的目的:
- 调查DEK在喘气道炎症中的作用.
- 阐明DEK在调节线粒细胞衰变,NLRP3炎症酶激活和亡中的机制.
- 在喘中识别DEK/ATAD3A/DRP1信号轴.
主要方法:
- 在小鼠 (WT和DEK-/-) 和BEAS-2B细胞中使用了家庭灰尘 (HDM) 和复合DEK (rmDEK) 诱导的喘模型.
- 评估了线粒 (PINK1-帕金因通路),NLRP3炎症酶激活,亡和反应性氧物种 (ROS) 生成.
- 采用了基因沉默 (siDEK,siATAD3A),特定抑制剂,ChIP序列和共免疫沉降.
主要成果:
- 在喘模型中,rmDEK促进了乙氨基细胞的招募,线粒,ROS生成,NLRP3炎症酶激活和亡.
- DEK 缺乏部分扭转了这些影响.
- DEK正调节了ATAD3A的表达,这反过来又影响了DRP1和线粒体损伤.
结论:
- 缺乏DEK可以通过降低PINK1-帕金因线粒细胞衰变,NLRP3炎症酶激活和亡来缓解喘中的呼吸道炎症.
- DEK/ATAD3A/DRP1信号轴与喘的病变发生有关.
- 这项研究确定了喘治疗的潜在治疗点.
相关概念视频
Asthma: Pathogenesis and Management
403
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Allergic Reactions
27.4K
Overview
27.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


